A detailed history of Voya Investment Management LLC transactions in Chroma Dex Corp. stock. As of the latest transaction made, Voya Investment Management LLC holds 18,508 shares of CDXC stock, worth $137,699. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18,508
Previous 18,679 0.92%
Holding current value
$137,699
Previous $50,000 34.0%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$2.51 - $3.8 $429 - $649
-171 Reduced 0.92%
18,508 $67,000
Q2 2024

Aug 14, 2024

BUY
$2.44 - $4.32 $45,576 - $80,693
18,679 New
18,679 $50,000
Q2 2022

Aug 15, 2022

SELL
$1.59 - $2.7 $28,472 - $48,348
-17,907 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$3.74 - $6.7 $4,069 - $7,289
-1,088 Reduced 5.73%
17,907 $67,000
Q2 2021

Aug 16, 2021

BUY
$6.66 - $10.92 $8,877 - $14,556
1,333 Added 7.55%
18,995 $187,000
Q1 2021

May 17, 2021

SELL
$4.59 - $18.74 $1,941 - $7,927
-423 Reduced 2.34%
17,662 $165,000
Q4 2020

Feb 16, 2021

BUY
$3.93 - $5.5 $14,485 - $20,273
3,686 Added 25.6%
18,085 $87,000
Q2 2020

Aug 14, 2020

SELL
$3.0 - $5.52 $24,015 - $44,187
-8,005 Reduced 35.73%
14,399 $66,000
Q4 2019

Feb 14, 2020

BUY
$2.83 - $4.61 $18,151 - $29,568
6,414 Added 40.11%
22,404 $97,000
Q3 2019

Nov 14, 2019

SELL
$3.83 - $4.72 $11,624 - $14,325
-3,035 Reduced 15.95%
15,990 $63,000
Q2 2019

Aug 14, 2019

BUY
$3.71 - $4.83 $12,476 - $16,243
3,363 Added 21.47%
19,025 $88,000
Q1 2019

May 15, 2019

SELL
$3.2 - $4.19 $14,172 - $18,557
-4,429 Reduced 22.04%
15,662 $66,000
Q2 2018

Aug 14, 2018

BUY
$3.22 - $4.43 $64,693 - $89,003
20,091 New
20,091 $75,000

Others Institutions Holding CDXC

About ChromaDex Corp.


  • Ticker CDXC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,350,896
  • Market Cap $509M
  • Description
  • ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...
More about CDXC
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.